Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials

Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review

(2020) Anton Gillessen et al.   ADVANCES IN THERAPY

Hepatotoxicity from Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation

(2020) Thoetchai (Bee) Peeraphatdit et al.   HEPATOLOGY

Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice

(2020) Tian-Ming Zhao et al.   Frontiers in Pharmacology

Polygenic architecture informs potential vulnerability to drug-induced liver injury

(2020) Masaru Koido et al.   NATURE MEDICINE

Prophylactic Therapy of Silymarin (Milk Thistle) on Antituberculosis Drug-Induced Liver Injury: A Meta-Analysis of Randomized Controlled Trials

(2019) Lina Tao et al.   Canadian Journal of Gastroenterology and Hepatology

Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2

(2019) Yuzhu Cao et al.   Frontiers in Pharmacology

EASL Clinical Practice Guidelines: Drug-induced liver injury

(2019) Raúl Andrade et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug‐induced liver injury: A phase II trial

(2019) Yongfeng Wang et al.   LIVER INTERNATIONAL

Drug-induced liver injury

(2019) Raul J. Andrade et al.   Nature Reviews Disease Primers

The Role of Tiopronin for the Prevention of Chemotherapy-Related Liver Toxicity in Advanced Colorectal Cancer Patients Treated with mFOLFOX7: A Prospective Analysis

(2018) Xiao-peng Li et al.   TUMORI

Corticosteroid therapy in drug-induced liver injury: pros and cons

(2018) Ping-Fang Hu et al.   Journal of Digestive Diseases

Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trial

(2017) Masoumeh Asgarshirazi et al.   Hepatobiliary & Pancreatic Diseases International

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

(2017) Yue-cheng Yu et al.   Hepatology International

N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury

(2017) Jürgen Borlak et al.   LIVER INTERNATIONAL

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats

(2017) Xin Liu et al.   MOLECULES

Magnesium isoglycyrrhizinate shows hepatoprotective effects in a cyclophosphamide-induced model of hepatic injury

(2017) Wenjiao Jiang et al.   Oncotarget

A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury

(2017) Wu Naiqiong et al.   MEDICAL SCIENCE MONITOR

Outcomes in Adults With Acute Liver Failure Between 1998 and 2013

(2016) Adrian Reuben et al.   ANNALS OF INTERNAL MEDICINE

N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review

(2016) Mohamed Farouk Chughlay et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial

(2016) Simin Zhang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

The anti-inflammatory activity of licorice, a widely used Chinese herb

(2016) Rui Yang et al.   PHARMACEUTICAL BIOLOGY

A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury

(2015) Chote Luangchosiri et al.   BMC Complementary and Alternative Medicine

Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway

(2015) Chunfeng Xie et al.   INFLAMMATION

The Role of Oxidative Stress and Antioxidants in Liver Diseases

(2015) Sha Li et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease

(2015) N-H. Chu et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

Drug-induced liver injury: Interactions between drug properties and host factors

(2015) Minjun Chen et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of acetylcysteine in “non-acetaminophen” acute liver failure: A meta-analysis of prospective clinical trials

(2015) Jinhua Hu et al.   Clinics and Research in Hepatology and Gastroenterology

Early monitoring for detection of antituberculous drug-induced hepatotoxicity

(2015) Chang Min Lee et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury

(2014) Naga P Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury

(2014) Mercedes Robles–Diaz et al.   GASTROENTEROLOGY

Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60 years of age with cancer

(2014) Xiaoyuan Li et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

(2013) Jelena Savović et al.   ANNALS OF INTERNAL MEDICINE

Steroid use in acute liver failure

(2013) Jamuna Karkhanis et al.   HEPATOLOGY

Carnitine for prevention of antituberculosis drug-induced hepatotoxicity: A randomized, clinical trial

(2013) Shima Hatamkhani et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: A placebo-controlled clinical trial

(2012) Robert H. Squires et al.   HEPATOLOGY

Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model

(2012) M Singh et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Hepatoprotective Efficacy of Ursodeoxycholic Acid in Pediatrics Acute Lymphoblastic Leukemia

(2012) Mojeb Mohammed Saif et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Case Definition and Phenotype Standardization in Drug-Induced Liver Injury

(2011) G P Aithal et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury

(2011) Alexander Wree et al.   DIGESTION

Causality assessment methods in drug induced liver injury: Strengths and weaknesses

(2011) Miren García-Cortés et al.   JOURNAL OF HEPATOLOGY

Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity

(2010) Shadi Baniasadi et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Carnitine in the treatment of valproic acid-induced toxicity

(2009) Philippe E.R. Lheureux et al.   CLINICAL TOXICOLOGY

Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure

(2009) William M. Lee et al.   GASTROENTEROLOGY

Bicyclol: A Novel Drug for Treating Chronic Viral Hepatitis B and C

(2009) Geng Liu   Medicinal Chemistry

Using controlled clinical trials to learn more about acute drug-induced liver injury

(2008) Paul B. Watkins et al.   HEPATOLOGY

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

(2008) Sude Eminzade et al.   Nutrition & Metabolism

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

(2008) Lesley Wood et al.   BMJ-British Medical Journal